Outcomes Following Discontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.

Abstract

BACKGROUND Discontinuation of E. coli l-asparaginase in patients with acute lymphoblastic leukemia (ALL) is unavoidable upon severe allergic reaction. We sought to examine outcomes following E. coli l-asparaginase discontinuation due to severe allergic reactions. PROCEDURE We evaluated the outcome of children enrolled in Taiwan Pediatric Oncology Group… (More)
DOI: 10.1002/pbc.25869

Topics

6 Figures and Tables

Slides referencing similar topics